Back to top

Company News For Sep 6, 2017

Read MoreHide Full Article
  • Shares of Insmed Inc. (INSM - Free Report) surged 120% after the company announced that it had completed the study of NTM lung disease and would now seek priority review and approval
  • Celectis S.A.’s (CLLS - Free Report) shares dropped 20% after the Food and Drug Administration ordered the drug company to stop its cancer-drug trial immediately
  • HB Fuller’s (FUL - Free Report) shares surged 2.5% after it entered into an agreement to purchase Royal Adhesives & Sealants for $1.58 billion
  • Shares of Alphabet Inc. (GOOGL - Free Report) tumbled 1.1% after news broke out that the European Commission could levy a record fine on the company’s Google unit 

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Alphabet Inc. (GOOGL) - free report >>

H. B. Fuller Company (FUL) - free report >>

Insmed, Inc. (INSM) - free report >>

Cellectis S.A. (CLLS) - free report >>

More from Zacks Corporate Summary

You May Like